PATENT CLAIM ANALYSIS

Application Number: 16364653
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["514", "356000"]

Abstract:
Disclosed herein are methods of treating disease with a combination of a RXR agonist and a thyroid hormone.

Claim (Index 27):
The method according to  claim 14 , wherein the thyroid hormone is administered directly to the central nervous system.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 99.0
- Lexical Diversity: 1.1875
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16296012', '16118001', '15339762', '15812821', '15339752']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.9025420932711492
- 35 USC 102 Novelty (BERT): 0.700520464656263
- Combined Prediction Score: 0.8823399304096607
- Mean Citation Score: 769.5742280000003
- Max Citation Score: 792.946
- Similarity Product: 688.2600901602507

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test